Blocking an inhibitory pathway within a subset of specialized T-cells may improve overall immune response against virally driven cancers, according to findings published in Nature.
Search Results: Head and Neck Cancer (6)
Fluorescent indocarbocyanine lipid labels show improved distribution within glioblastoma brain tumors, according to a Northwestern Medicine study.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
Jerilyn Ann Logemann, ’68 PhD, professor in Neurology and Otolaryngology – Head and Neck Surgery, died June 19 at age 72.
In Memoriam (George Sisson Sr.)George A. Sisson Sr., MD, emeritus professor of otolaryngology—head and neck surgery, died August 6 after…
In Memoriam (Charles Staley)Charles J. “Tod” Staley, MD, associate professor emeritus of surgery at the Feinberg School, died February 19…